Featured
Want to learn more about 8th DIA Annual Conference in Japan for Asian New Drug Development? You've come to the right site!
Program Committee
-
Hidetoshi Shuto Senior Fellow, Corporate Technology Sector
Nitto Denko Corporation, Japan -
Ari Fujishiro Senior Director, Regulatory Affairs Group, Asia Development Dept., R&D Division
Daiichi Sankyo Co., Ltd., Japan -
Tomohisa Hayakawa, PHD Corporate Officer; Head of BD & PM
EPS International Holdings Co., Ltd., Japan -
Shii Man, MD, PHD
Otsuka Beijing Research Institute, China -
Koichi Miyazaki, PHD Senior Director, Group IV, Oncology Clinical Development Department
Daiichi Sankyo Co., Ltd., Japan -
Yasuto Otsubo Review Director, Office of New Drug II
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Minsoo Park
KCGI, Korea, Republic of -
Kihito Takahashi Head of R&D/Medical Affairs Hub Japan
Swedish Orphan Biovitrium (SOBI) Japan, Japan -
Akio Uemura, PHD Senior Advisor
AU Consulting, Co., Japan -
Yoshiaki Uyama, PHD, MS, RPH Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Jisin Yang, MD Global Clinical Program Director, Japan R&D
CSL Behring K.K., Japan
Have an account?